---
title: Buy Aromasin (Exemestane) 25mg Pills Online
description: Aromasin (Exemestane) 25mg from Pfizer treats advanced breast cancer in postmenopausal women. Securely order from our verified pharmacy.
type: product
language: en 
url: https://liabilis.com/order-aromasin-online-en.html
availability: in_stock
shipping:
  - type: Standard Airmail
    price: 10.00
    currency: USD
    area: Worldwide
    time: 14-21 days
  - type: Tracked Express
    price: 30.00
    currency: USD
    area: Worldwide
    tracking: true
    time: 5-9 days
price_min: 200.99
price_max: 668.99
currency: USD
offers:
  - name: 25mg x 30 pills
    price: 200.99
  - name: 25mg x 60 pills
    price: 371.99
  - name: 25mg x 90 pills
    price: 539.99
  - name: 25mg x 120 pills
    price: 668.99
---

# Buy Aromasin (Exemestane) 25mg Pills Online

Aromasin, containing Exemestane and developed by Pfizer, is an aromatase inhibitor for postmenopausal women with hormone receptor-positive advanced breast cancer. It reduces estrogen production to slow tumor growth. Available in 25mg pills from our trusted online pharmacy.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **25mg** | 30 pills | **$200.99** | $6.70 | In Stock |
| **25mg** | 60 pills | **$371.99** | $6.20 | In Stock |
| **25mg** | 90 pills | **$539.99** | $6.00 | In Stock |
| **25mg** | 120 pills | **$668.99** | $5.57 | In Stock |


[Buy Now](https://liabilis.com/order-aromasin-online-en.html)

## Introduction 
Aromasin is a oral medication that contains the active ingredient exemestane, an irreversible aromatase inhibitor. It is supplied as a 25 mg tablet and belongs to the class of endocrine therapy agents used primarily in the treatment of hormone-responsive breast cancer in postmenopausal women. By blocking the conversion of androgens to estrogens, Aromasin reduces circulating estrogen levels, helping to slow or stop the growth of estrogen-dependent tumors. The drug may also be employed in selected off-label situations where estrogen suppression is desired.

## Quick Reference Facts 

**Active Ingredient** 
: Exemestane 

**Form** 
: Pill 25 mg 

**Primary and Off-Label Uses** 
: • Treatment of estrogen-receptor positive breast cancer (postmenopausal) 
: • Hormone suppression in assisted reproductive protocols (off-label) 
: • Management of estrogen-related conditions such as gynecomastia in men (off-label) 

## What is Aromasin? 
Aromasin is the generic version of medications that contain the steroidal aromatase inhibitor exemestane. It is classified as an endocrine therapy agent that reduces estrogen production by permanently inactivating the aromatase enzyme. The drug was originally developed by Amgen and launched under the brand name Aromasin; today it is widely available as a generic tablet, offering the same pharmacologic profile at lower cost. Aromasin is manufactured by several licensed pharmaceutical firms that meet international quality standards, and it is marketed globally for the management of hormone-sensitive breast cancer in postmenopausal patients. Generic equivalents of Aromasin are often found under the simple name exemestane, and the medication is sometimes referenced alongside other aromatase inhibitors such as letrozole and anastrozole.

## How Aromasin Works 
Exemestane, the active molecule in Aromasin, binds irreversibly to the aromatase enzyme’s active site. Aromatase normally catalyzes the conversion of androstenedione and testosterone into estrone and estradiol, respectively. By forming a covalent bond with the enzyme, exemestane permanently disables its activity, leading to a sustained reduction in peripheral estrogen synthesis. The result is a marked decline in circulating estradiol levels, typically by 70-90 % within the first week of therapy. 

Because exemestane is a steroidal (type I) inhibitor, its binding mimics the natural substrate but cannot be displaced by other compounds, giving it a prolonged effect even after plasma concentrations fall. The drug is absorbed well after oral administration, reaches peak plasma levels in approximately 2-3 hours, and is metabolized primarily by the liver via CYP3A4 to an inactive hydroxy-exemestane metabolite. Elimination occurs chiefly through feces, with a terminal half-life of about 24 hours, supporting once-daily dosing. 

The irreversible nature of aromatase inhibition explains the drug’s efficacy in estrogen-dependent cancers and also underlies the need for careful monitoring of bone health and lipid profiles, as prolonged low-estrogen states can affect these systems.

## Conditions Treated with Aromasin 

- **Estrogen-Receptor Positive Breast Cancer (postmenopausal)** 
 Aromasin lowers estrogen levels that fuel tumor growth, making it an effective adjuvant therapy after surgery or radiation. Clinical trials have shown it reduces recurrence risk compared with placebo.

- **Adjuvant Therapy After Tamoxifen** 
 Switching to exemestane following 2-3 years of tamoxifen provides continued estrogen suppression, improving disease-free survival in many treatment protocols.

- **Metastatic Breast Cancer** 
 For patients with advanced disease not responding to non-steroidal aromatase inhibitors, Aromasin offers an alternative mechanism of action that can achieve tumor stabilization.

*(Only these regulatory-approved indications are listed; other uses are considered off-label.)*

## Is Aromasin the Right Medication for You? 
Aromasin is most appropriate for postmenopausal women diagnosed with estrogen-receptor positive breast cancer who require systemic hormone suppression. It is also considered when patients have progressed on non-steroidal aromatase inhibitors or when a steroidal agent is preferred for its distinct binding profile. 

Patients with a history of severe osteoporosis, active thromboembolic disease, or premenopausal status should discuss alternative therapies, as the profound estrogen reduction may exacerbate bone loss or be ineffective without menopause. Women who are pregnant, lactating, or planning pregnancy must avoid Aromasin because of potential fetal toxicity. 

In clinical practice, Aromasin is recommended for individuals who can tolerate daily oral dosing, have adequate liver function, and are under close monitoring for bone mineral density and lipid changes. Shared decision-making with an oncologist ensures the benefits outweigh the risks for each patient.

## Buying Aromasin from [our online pharmacy](https://liabilis.com/order-aromasin-online-en.html) 

### Why Choose Our Service? 
Accessing Aromasin can be challenging due to insurance restrictions or regional availability. Our pharmacy service provides a convenient, cost-effective way to obtain the medication, especially for patients seeking a reliable generic alternative.

### Quality & Safety Assurance 
We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of Aromasin is sourced from manufacturers that comply with Good Manufacturing Practice (GMP) standards and undergo independent verification.

### Pricing & Access 
Because Aromasin is offered as a generic tablet, the price is typically close to the manufacturer’s nominal cost, delivering significant savings compared with brand-name equivalents. Our platform makes the medication available even in regions where local pharmacies stock limited quantities.

### Discreet Delivery 
Orders are packaged in unmarked, tamper-evident envelopes and dispatched via express carriers that usually deliver within 7 days. Standard airmail takes approximately three weeks, ensuring privacy and convenience for all patients.

## Use: Dosing, Missed Dose, Overdose 

- **Standard Dosing** 
 The usual adult dose for breast cancer treatment is one 25 mg tablet taken orally once daily, preferably at the same time each day. Food does not significantly affect absorption, so the tablet may be taken with or without meals.

- **Missed Dose** 
 If a dose is forgotten, take it as soon as remembered **unless** it is within 12 hours of the next scheduled dose. In that case, skip the missed tablet and resume the regular dosing schedule. Do not double-dose.

- **Suspected Overdose** 
 Symptoms may include nausea, vomiting, fatigue, or dizziness. In case of an overdose, seek immediate medical attention; treatment is supportive and may involve activated charcoal if presentation is early.

- **Practical Precautions** 
 • Avoid concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole) without medical guidance. 
 • Limit alcohol intake, as excessive consumption can increase liver load. 
 • Do not operate heavy machinery if you experience dizziness or severe fatigue.

## Safety Information 

### ⚠️ Who Should Not Take Aromasin 
- Premenopausal women (insufficient estrogen suppression) 
- Pregnant or breastfeeding individuals 
- Patients with known hypersensitivity to exemestane or any excipients in the tablet 
- Individuals with severe uncontrolled liver disease 

### Common Side Effects 
- **Hot flashes** (occurs in 30-50 % of patients): transient warmth and sweating; can be managed with lifestyle adjustments. 
- **Joint or muscle aches** (15-30 %): usually mild; analgesics such as acetaminophen may help. 
- **Fatigue** (10-20 %): energy conservation and moderate exercise are recommended. 
- **Nausea or mild gastrointestinal upset** (10 %): taking the tablet with food can reduce discomfort. 

### Serious Side Effects (Seek Immediate Medical Help) 
- **Deep vein thrombosis or pulmonary embolism**: sudden leg swelling, chest pain, or shortness of breath. 
- **Severe osteoporosis or pathological fractures**: persistent bone pain, loss of height, or fragility fractures. 
- **Liver enzyme elevation**: jaundice, dark urine, or severe abdominal pain. 

If any of these symptoms develop, discontinue Aromasin and contact a healthcare professional promptly.

### Drug & Food Interactions 
- **CYP3A4 inhibitors (e.g., ketoconazole, itraconazole)** - may increase exemestane plasma levels; dose adjustment may be required. 
- **CYP3A4 inducers (e.g., rifampin, carbamazepine)** - may reduce efficacy by lowering drug concentration. 
- **Estrogen-containing therapies (hormone replacement, oral contraceptives)** - antagonistic effect; simultaneous use diminishes therapeutic benefit. 
- **Anticoagulants (warfarin)** - monitor INR more closely, as estrogen suppression can alter clotting risk. 

Patients should always discuss all current medications, supplements, and dietary habits with their prescriber before initiating Aromasin.

## Off-Label and Investigational Uses of Aromasin 

- **Management of Gynecomastia in Men** - Small clinical series have reported reduction of breast tissue size when exemestane is used to lower circulating estrogen in male patients receiving anabolic steroids. 
- **Adjunct in Male Hypogonadism Treatment** - Some endocrinology practices employ low-dose exemestane to prevent estrogen feedback during testosterone replacement therapy, thereby optimizing testosterone levels. 
- **Fertility Protocols** - Exemestane has been investigated as an alternative to clomiphene for ovulation induction in women with polycystic ovary syndrome, offering a shorter half-life and fewer anti-estrogenic side effects. 

These applications are not approved by regulatory agencies; their safety and efficacy remain under investigation, and use should occur only under specialist supervision.

## Storage & Handling 

- Keep tablets in the original container, tightly closed, at room temperature (20-25 °C). 
- Protect from moisture, excessive heat, and direct sunlight. 
- Do not store in the bathroom or near a kitchen sink. 
- Discard any tablets that appear discolored, crumbling, or past the expiration date. 
- Return unused medication to a pharmacy collection point or follow local hazardous waste guidelines for disposal.

## Frequently Asked Questions 

**Practical Use & Lifestyle** 

- **Can I travel internationally with Aromasin tablets?** 
 Yes, but carry the medication in its original packaging with a copy of the prescription or a physician’s letter to satisfy customs regulations in most countries. 

- **Should I avoid calcium supplements while taking Aromasin?** 
 Calcium does not interfere with exemestane absorption, but patients at risk for osteoporosis are often advised to take calcium and vitamin D supplements to protect bone health. 

- **Is it safe to take Aromasin while exercising?** 
 Regular weight-bearing exercise is encouraged to mitigate bone loss. However, if you experience severe joint pain, consult your doctor before continuing high-impact activities. 

**Product & Formulation Details** 

- **What do Aromasin tablets look like?** 
 The 25 mg tablet is typically round, white, and imprint-marked with “A” on one side and “25” on the other, though appearance can vary slightly between manufacturers. 

- **Can the tablet be split or crushed?** 
 Exemestane tablets are not scored, and splitting may result in dose inaccuracy. Crushing is unnecessary because the drug is well absorbed as a whole tablet. 

**Regulatory & Safety Nuances** 

- **Will Aromasin show up on a standard drug test?** 
 Exemestane is not commonly screened for in employment or athletic drug tests, as it is not a prohibited substance under most anti-doping regulations. 

- **Is Aromasin classified as safe for elderly patients?** 
 Elderly patients may be more susceptible to bone loss and cardiovascular effects; dose adjustments are not needed, but clinicians monitor bone density and lipid profiles more closely. 

- **Can I obtain Aromasin without a prescription?** 
 No, Aromasin is a prescription-only medication in all regulated jurisdictions. Purchasing it without a valid prescription is illegal and may compromise safety. 

**Scientific & Clinical Curiosity** 

- **How does exemestane differ from non-steroidal aromatase inhibitors?** 
 Exemestane binds irreversibly and mimics the natural substrate, whereas non-steroidal agents such as anastrozole bind reversibly. This permanent inactivation can lead to a longer pharmacodynamic effect despite a similar half-life. 

- **What was the pivotal trial that led to Aromasin approval?** 
 The pivotal phase III trial (the “MA-27” study) compared exemestane to placebo in postmenopausal women with early-stage breast cancer, demonstrating a statistically significant improvement in disease-free survival. 

## Glossary 

**Aromatase Inhibitor** 
: A class of drugs that block the enzyme aromatase, preventing the conversion of androgens to estrogens. 

**Irreversible Inhibitor** 
: A compound that forms a permanent covalent bond with its target enzyme, rendering the enzyme inactive for the remainder of its lifespan. 

**Bone Mineral Density (BMD)** 
: A measurement of the amount of mineral matter per square centimeter of bone, used to assess osteoporosis risk. 

**CYP3A4** 
: A liver enzyme responsible for metabolizing many drugs; inhibitors or inducers of CYP3A4 can alter the effectiveness of co-administered medications. 

**Good Manufacturing Practice (GMP)** 
: Regulatory standards that ensure pharmaceutical products are consistently produced and controlled according to quality standards. 

## Disclaimer 

The information presented about **Aromasin** serves educational purposes only and is not a substitute for professional medical advice. All therapeutic decisions, including those involving off-label applications, should be made under the guidance of a qualified healthcare provider. Readers are presumed to be responsible adults capable of making informed health choices. [our online pharmacy](https://liabilis.com/order-aromasin-online-en.html) supplies Aromasin to individuals who may encounter limited access through conventional channels or who seek cost-effective generic alternatives. Prior to initiating, altering, or discontinuing any medication, please consult your physician or pharmacist.